Shortages of Adderall (mixed amphetamine salts), the renowned treatment for attention deficit hyperactivity disorder and narcolepsy, and its generic equivalents is now headline news in the US, with widespread reports of patients being told that prescriptions are on backorder for up to several months.
Shortages were reported by the US Food and Drug Administration as far back as the third quarter of 2019. Three...




